vs

Side-by-side financial comparison of FARMERS NATIONAL BANC CORP (FMNB) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.

FARMERS NATIONAL BANC CORP is the larger business by last-quarter revenue ($71.5M vs $47.7M, roughly 1.5× IRONWOOD PHARMACEUTICALS INC). FARMERS NATIONAL BANC CORP runs the higher net margin — 20.5% vs -4.8%, a 25.2% gap on every dollar of revenue. On growth, FARMERS NATIONAL BANC CORP posted the faster year-over-year revenue change (3.2% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $52.2M). Over the past eight quarters, FARMERS NATIONAL BANC CORP's revenue compounded faster (6.2% CAGR vs -20.2%).

Farmers National Banc Corp (OH) is a regional financial holding company based in Ohio, the United States. It offers full-spectrum retail and commercial banking products, wealth management solutions, and insurance services, primarily catering to individual consumers, small and medium-sized enterprises, and local community clients in Ohio and adjacent Midwestern U.S. regions.

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

FMNB vs IRWD — Head-to-Head

Bigger by revenue
FMNB
FMNB
1.5× larger
FMNB
$71.5M
$47.7M
IRWD
Growing faster (revenue YoY)
FMNB
FMNB
+50.5% gap
FMNB
3.2%
-47.3%
IRWD
Higher net margin
FMNB
FMNB
25.2% more per $
FMNB
20.5%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$22.4M more FCF
IRWD
$74.6M
$52.2M
FMNB
Faster 2-yr revenue CAGR
FMNB
FMNB
Annualised
FMNB
6.2%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FMNB
FMNB
IRWD
IRWD
Revenue
$71.5M
$47.7M
Net Profit
$14.6M
$-2.3M
Gross Margin
Operating Margin
24.8%
14.3%
Net Margin
20.5%
-4.8%
Revenue YoY
3.2%
-47.3%
Net Profit YoY
1.7%
-200.9%
EPS (diluted)
$0.39
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FMNB
FMNB
IRWD
IRWD
Q4 25
$71.5M
$47.7M
Q3 25
$70.8M
$122.1M
Q2 25
$69.8M
$85.2M
Q1 25
$67.8M
$41.1M
Q4 24
$69.3M
$90.5M
Q3 24
$70.3M
$91.6M
Q2 24
$66.5M
$94.4M
Q1 24
$63.4M
$74.9M
Net Profit
FMNB
FMNB
IRWD
IRWD
Q4 25
$14.6M
$-2.3M
Q3 25
$12.5M
$40.1M
Q2 25
$13.9M
$23.6M
Q1 25
$13.6M
$-37.4M
Q4 24
$14.4M
$2.3M
Q3 24
$8.5M
$3.6M
Q2 24
$11.8M
$-860.0K
Q1 24
$11.2M
$-4.2M
Operating Margin
FMNB
FMNB
IRWD
IRWD
Q4 25
24.8%
14.3%
Q3 25
20.7%
61.8%
Q2 25
23.4%
53.2%
Q1 25
24.1%
-70.7%
Q4 24
25.5%
34.8%
Q3 24
14.4%
28.0%
Q2 24
21.3%
26.5%
Q1 24
21.2%
14.7%
Net Margin
FMNB
FMNB
IRWD
IRWD
Q4 25
20.5%
-4.8%
Q3 25
17.6%
32.8%
Q2 25
19.9%
27.7%
Q1 25
20.0%
-90.9%
Q4 24
20.8%
2.5%
Q3 24
12.1%
4.0%
Q2 24
17.7%
-0.9%
Q1 24
17.7%
-5.6%
EPS (diluted)
FMNB
FMNB
IRWD
IRWD
Q4 25
$0.39
$0.01
Q3 25
$0.33
$0.23
Q2 25
$0.37
$0.14
Q1 25
$0.36
$-0.23
Q4 24
$0.38
$0.03
Q3 24
$0.23
$0.02
Q2 24
$0.31
$-0.01
Q1 24
$0.30
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FMNB
FMNB
IRWD
IRWD
Cash + ST InvestmentsLiquidity on hand
$215.5M
Total DebtLower is stronger
$86.7M
Stockholders' EquityBook value
$485.7M
$-261.8M
Total Assets
$5.2B
$396.9M
Debt / EquityLower = less leverage
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FMNB
FMNB
IRWD
IRWD
Q4 25
$215.5M
Q3 25
$140.4M
Q2 25
$92.9M
Q1 25
$108.5M
Q4 24
$88.6M
Q3 24
$88.2M
Q2 24
$105.5M
Q1 24
$121.5M
Total Debt
FMNB
FMNB
IRWD
IRWD
Q4 25
$86.7M
Q3 25
$86.6M
$199.5M
Q2 25
$86.4M
$199.3M
Q1 25
$86.3M
$199.2M
Q4 24
$86.2M
$199.0M
Q3 24
$86.0M
$198.8M
Q2 24
$88.9M
$198.6M
Q1 24
$88.8M
$398.3M
Stockholders' Equity
FMNB
FMNB
IRWD
IRWD
Q4 25
$485.7M
$-261.8M
Q3 25
$465.9M
$-264.2M
Q2 25
$437.7M
$-308.2M
Q1 25
$429.1M
$-334.1M
Q4 24
$406.0M
$-301.3M
Q3 24
$439.7M
$-311.3M
Q2 24
$396.7M
$-321.7M
Q1 24
$397.0M
$-330.5M
Total Assets
FMNB
FMNB
IRWD
IRWD
Q4 25
$5.2B
$396.9M
Q3 25
$5.2B
$396.1M
Q2 25
$5.2B
$342.9M
Q1 25
$5.2B
$327.2M
Q4 24
$5.1B
$350.9M
Q3 24
$5.2B
$389.5M
Q2 24
$5.2B
$395.6M
Q1 24
$5.1B
$438.8M
Debt / Equity
FMNB
FMNB
IRWD
IRWD
Q4 25
0.18×
Q3 25
0.19×
Q2 25
0.20×
Q1 25
0.20×
Q4 24
0.21×
Q3 24
0.20×
Q2 24
0.22×
Q1 24
0.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FMNB
FMNB
IRWD
IRWD
Operating Cash FlowLast quarter
$60.0M
$74.6M
Free Cash FlowOCF − Capex
$52.2M
$74.6M
FCF MarginFCF / Revenue
73.0%
156.3%
Capex IntensityCapex / Revenue
11.0%
0.0%
Cash ConversionOCF / Net Profit
4.10×
TTM Free Cash FlowTrailing 4 quarters
$85.8M
$127.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FMNB
FMNB
IRWD
IRWD
Q4 25
$60.0M
$74.6M
Q3 25
$10.7M
$47.6M
Q2 25
$14.0M
$-15.1M
Q1 25
$15.7M
$20.0M
Q4 24
$66.6M
$15.2M
Q3 24
$23.9M
$9.9M
Q2 24
$16.6M
$33.5M
Q1 24
$13.7M
$45.0M
Free Cash Flow
FMNB
FMNB
IRWD
IRWD
Q4 25
$52.2M
$74.6M
Q3 25
$9.0M
$47.6M
Q2 25
$12.4M
$-15.1M
Q1 25
$12.2M
$19.9M
Q4 24
$54.9M
Q3 24
$20.4M
$9.9M
Q2 24
$14.4M
$33.4M
Q1 24
$12.2M
$44.9M
FCF Margin
FMNB
FMNB
IRWD
IRWD
Q4 25
73.0%
156.3%
Q3 25
12.8%
39.0%
Q2 25
17.8%
-17.7%
Q1 25
18.0%
48.4%
Q4 24
79.2%
Q3 24
29.1%
10.8%
Q2 24
21.6%
35.4%
Q1 24
19.2%
60.0%
Capex Intensity
FMNB
FMNB
IRWD
IRWD
Q4 25
11.0%
0.0%
Q3 25
2.4%
0.0%
Q2 25
2.3%
0.0%
Q1 25
5.2%
0.1%
Q4 24
16.9%
0.0%
Q3 24
4.9%
0.0%
Q2 24
3.3%
0.1%
Q1 24
2.4%
0.1%
Cash Conversion
FMNB
FMNB
IRWD
IRWD
Q4 25
4.10×
Q3 25
0.86×
1.19×
Q2 25
1.01×
-0.64×
Q1 25
1.15×
Q4 24
4.63×
6.74×
Q3 24
2.80×
2.71×
Q2 24
1.41×
Q1 24
1.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons